medical device investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
pharmaceutical investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
medical device investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical investing Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial
Blue Lagoon Secures $2 Million Line of Credit from Nicola Mining Enhancing Financial Flexibility Ahead of Production
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements
